NYSE · Healthcare
Inspire Medical Systems, Inc. (INSP)
As-reported financials and recent SEC filings for Inspire Medical Systems, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$912.0M
Net income
$145.4M
Net margin
15.9%
Diluted EPS
$4.89
ROE
18.6%
P/E (TTM)
10.4×
Market cap
$1.32B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $912.0M | $802.8M | $624.8M | $407.9M | $233.4M |
| Gross profit | $778.8M | $679.8M | $528.2M | $341.7M | $200.1M |
| Operating income | $51.0M | $36.1M | $-40.3M | $-47.6M | $-39.9M |
| Net income | $145.4M | $53.5M | $-21.2M | $-44.9M | $-42.0M |
| Diluted EPS | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-26
View on EDGAR →SD2026-06-01
View on EDGAR →SCHEDULE 13G2026-05-27
View on EDGAR →42026-05-19
View on EDGAR →1442026-05-15
View on EDGAR →42026-05-15
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →1442026-05-14
View on EDGAR →Go deeper on INSP
Search Inspire Medical Systems, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.